C hronic otitis media (COM) is a major health problem, especially in developing and underdeveloped countries. The chronic nature of the disease can lead to repeated hospital visits and increased financial burden, hearing loss, and related social problems concerning ear discharge, education/learning difficulties, and especially in untreated cases, life-threatening complications.
Otorhinolaryngology and Head and Neck Surgery Clinic of the Etfal Training and Research Hospital between 2014 and 2017 were included in the study. The study was approved by the Ethics Committee of our hospital (approval number, 1764). The patients' data were obtained from the clinic archives. Age, gender, ear examination findings, audiologic test results, tomography reports and radiological images of the patients, the type of operation performed, and surgical findings were transferred to the computer environment.
The patients were divided into two groups, considering the condition of the ear and the operation performed. Group 1 included bad ears, and Group 2 dry ears. Bad ears were characterized by cholesteatomas, suppurative, and/or malodorous COM unresponsive or partially responsive to treatment, polyp in the middle ear or extending to external ear, edematous and hypertrophic middle ear mucosa, retraction pockets of tympanic membrane from inside cholesteatoma or aspirated squamous epithelial cells, radiologically defined loss of significant aeriation in the middle ear and mastoid, destruction of bone structures, and complicated COM. Mastoidectomy was added to the surgical treatment of all the patients in this group. Dry ears are characterized by priorly with hearing loss , centrally perforated ears without discharge, otorrhea responsive to treatment, naturally appearing middle ear mucosa without retraction pockets, and those treated only with tympanoplasty and without additional mastoidectomy or atticotomy. The treated ear was defined as the ipsilateral and opposite ear as the contralateral ear.
In the contralateral tympanic membranes of the patients in both groups (bad and dry ears), (1) perforation, (2) retraction, (3) myringosclerosis, (4) atrophy/pseudomembrane, or (5) natural examination findings were noted. After dividing retractions as pars tensa and pars flaxida perforations, they were categorized as mild/moderate and severe retractions according to the Sade and Berco [1] classification (Table  1) . According to pure-tone audiometry results, all patients' 500, 1000, 2000, and 4000 Hertz average pure-tone air and bone conduction threshold values were recorded.
Patients who had undergone exploratory tympanotomy, stapedectomy/stapedotomy, revision ear surgery, ear tumor surgery, were under 18 years of age, had implanted paracentesis or ventilation tube, patients receiving only medical treatment, cases whose examination findings, surgical notes, audiologic examination or imaging (for patients with mastoidectomy) data could not be obtained were excluded from the study.
Adult patients with complicated or uncomplicated COM treated with tympanoplasty and tympanomastoidectomy were included in the study.
Both groups were compared in terms of contralateral ear findings. The SPSS version 15.0 (for Windows) was used for statistical analysis.
Descriptive statistics: categorical variables were expressed as numbers and percentages, and numerical variables as the mean, standard deviation, minimum, maximum, and median values. Since the numerical variables did not meet the conditions of normal distribution, two independent group comparisons were made using the Mann-Whitney U test. The ratios of the categorical variables among the groups were tested using the chi-squared analysis. The Monte Carlo simulation test was applied when the conditions were not met. The statistically significant level of alpha was accepted as p<0.05.
Results
Group 1 (bad ears) consisted of 68 (60.7%) male and 44 (39.3%) female patients, and the age range was 18-76 (42.9±14.4) years. In Group 2 (dry ears), there were 96 (52.5%) male and 87 (47.5%) female patients, and the age range was 18-68 (35.4±12.0) years. Accordingly, the mean age of the patients in Group 1 was higher than Group 2, and this difference was statistically significant (p<0.001). There was no significant difference between the two groups in terms of gender (p>0.05) ( Table 2 ).
When two groups were compared in terms of otoscopic findings, 42.0% of the contralateral ears in Group 1 were Table 1 . Classification of tympanic membrane pars tensa, and pars flaxida retractions according to Sade and Berco natural, and 56.8% of the contralateral ears in Group 2 were natural, and this difference was statistically significant (p=0.013) ( Table 3) . According to this, abnormal otoscopic findings were detected in 58% and 43.2% of the contralateral ears in Groups 1 and 2, respectively.
Mild/moderate retraction rates in the contralateral ears in Groups 1 and 2 were 20.5, and 6.6%, respectively, with a statistically significant intergroup difference (p=0.001) ( Table 3 ).
The rates of hearing loss in the contralateral ear were 63.4% in Group 1 and 46.4% in Group 2 (p=0.005) ( Table 3) . When the groups were compared in terms of pure-sound hearing averages, both air and bone conduction averages were higher in Group 1 than in Group 2, and differences between groups were statistically significant (p<0.001, p<0.001, respectively) (Table 3 ).
There was no statistically significant difference between groups in terms of perforation, severe retraction of pars tensa, mild/moderate and severe retraction of pars flaxida, myringosclerosis, and atrophy (p>0.05) ( Table 3 ). There was no statistically significant difference between groups in terms of the level and type of hearing loss (p>0.05) ( Table 3) .
Discussion
Otitis media is a common disease worldwide. According to the literature, the prevalence of COM varies between 0.5% and 30%, affecting over 20 million people worldwide. [2, 3] The annual cost of the disease has been reported as $5 million in the United States. [4] COM is characterized by the perforation of the eardrum, recurrent otorrhea and hearing loss, and histopathological inflammation in the middle ear mucosa and sometimes irreversible tissue damage. The disease develops within a This continuity model, suggested in the development of COM, discloses the progressive nature of the disease. [4] [5] [6] According to this theory, COM may come in the form of different pathological phases. The stages observed in the development of the disease can also manifest itself in the contralateral ear. In a series of 500 patients with COM, abnormal otoscopic examination findings were detected in 75% of the contralateral ears of the patients. [7] In another study, audiometric hearing loss was detected in the contralateral ears of 30% patients with COM. [8] Chalton and Stearns [9] reported pathologic otoscopic findings in 53% of the contralateral ears of 73 patients who underwent canal wall-down tympanomastoidectomy due to cholesteatoma, and most of these cases were pars tensa retractions.
Based on these studies, detection, evaluation, and early treatment of contralateral ear pathologies that can be seen simultaneously in patients with COM may prevent disease progression and reduce treatment costs and complication rates associated with the disease. For this purpose, contralateral ear findings of the patients who were operated on for COM in our clinic were retrospectively screened.
We aimed to determine the findings of the contralateral ears by forming two groups according to the severity level of the operated ear. Group 1 included ears with destructive radiological findings with limited response or no response to the treatment, ears with cholesteatoma, polyps, or hypertrophic middle ear mucosa, and therefore additionally underwent surgical treatment with mastoidectomy. Group 2 included dry ears, otorrhea that responded to treatment, patients predominantly with hearing loss, and patients treated with tympanoplasty.
Examination and audiological findings of the contralateral ears of the two groups were compared. Accordingly, pathological otoscopic findings were detected in 58% and 43.2% of the contralateral ears of the bad and dry ear patients, respectively.
Consistent with the literature, pathological findings at varying levels in the contralateral ears of patients with COM support the tendency of the ears to be affected bilaterally, and these features are observed to be more severe on the diseased side.
When the contralateral ears were viewed from the tympanic membrane retraction angle, a mild/moderate pars tensa retraction was observed in 6.6% of dry ears and three times higher (20.5%) in the bad ears. However, severe pars tensa retraction did not show a statistically significant difference between the two groups. There was no significant difference in the comparison of groups in terms of pars flaxida retractions. However, in the literature, contralateral tympanic membrane retractions were not divided as pars tensa and pars flaxida retractions in some studies, and they were all evaluated all together. [7, 10] In our study, tympanic membrane retraction was observed in 33 (33/112) (29.46%) patients in the bad ear and 20 (20/183) (10.9%) patients in dry ear groups. An approximately 3 times higher number of retractions that was observed in the contralateral ear in the bad ear group and the presence of older patients in this group also suggest that the duration of the disease should be considered in retraction formation and in the progress to chronicity.
Since tympanic membrane retraction is an important step in initiating the process toward formation of chronic otitis, it is the only otoscopic finding that made a difference in our study. As a matter of fact, perforation, myringosclerosis, and atrophy of the ear membrane did not show any significant differences between the groups.
When the hearing level in the contralateral ear was examined, hearing loss was found in 71 (71/112) (63.4%) patients in the bad and 85 (18/46) (46.4%) patients in the dry ear groups. When the bone and air-conduction thresholds were compared between the groups, mean air conduction threshold values were 29.4±18.1 in Group 1, and 23.5±18.0 in Group 2, and the mean air-conduction threshold value was found to be statistically higher in Group 1. Similarly, the mean bone conduction threshold values were 17.8±13.5 and 12.4 ±11.8 in Groups 1 and 2, respectively, and the Group 1 thresholds were significantly higher than those in Group 2.
Increased bone conduction threshold values in Group 1 may be explained by the higher average age of this group. However, the fact that the higher mean air conduction threshold values are in Group 1 may be a result of statistically significant increase in pathologic otoscopic findings in this group compared to Group 2.
Detailed and thorough examination of both ears in COM patients plays a key role in the prognostic evaluation of each patient, because the ear with COM can give an idea concerning pathological progression in the contralateral ear. Therefore, it is important that the contralateral ear is very well monitored, particularly in bad ears. Indeed, the ears should be analyzed as a pair, not as a separate unit. COM occurring in one ear can be useful in predicting the possible clinical course of the other ear.
In conclusion, according to this study, approximately half of COM patients have pathological findings in the contra-lateral ear. Since etiologic factors may affect both ears, and COM has a tendency to progress, it is important that the contralateral ear should be evaluated as carefully and detailed as the ipsilateral ear. Among pathological findings, especially tympanic membrane retractions in the contralateral ear are remarkable.
This finding indicates the importance of retraction in the developmental process progressing to COM. However, ipsilateral ear findings may give an idea about possible clinical course of the contralateral ear. This is the reason why both ears should be evaluated as a whole. Detection, follow-up, and early treatment of pathologic findings of the contralateral ear have clinical importance in terms of preventing or delaying the development of potential COM.
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